MedTech company, Intercus GmbH, receives seven-figure growth investment from bm|t

bm|t, the lead­ing growth investor in Thürin­gen, Ger­many, has invested a seven-fig­ure sum in Inter­cus GmbH from Bad Blankenburg.

For over 15 years, Inter­cus GmbH has pro­duced inno­v­a­tive implants for the trauma and ortho­pe­dic mar­kets. With this invest­ment the com­pany plans to bring fur­ther inno­v­a­tive prod­ucts to mar­ket and drive its sales growth.

Thomas Busch, CEO, is con­vinced that Inter­cus has found a reli­able and for­ward-think­ing investor to help the com­pany cap­i­tal­ize on attrac­tive growth opportunities.

bm|t invested in Inter­cus via one of its man­aged funds, the Mit­tel­stands-Fonds Thürin­gen (MFT). The MFT fund invests in estab­lished mid-sized com­pa­nies that have strong growth potential.

More infor­ma­tion about Inter­cus can be found here: https://www.intercus.de